Persistence of SARS-CoV-2 total immunoglobulins in a series of convalescent plasma and blood donors

被引:3
作者
Carmen Martin, M. [1 ]
Jimenez, Ana [1 ]
Ortega, Nuria [1 ]
Parrado, Alba [1 ]
Page, Isabel [1 ]
Isabel Gonzalez, M. [1 ]
Blanco-Peris, Lydia [1 ]
机构
[1] Ctr Hemoterapia & Hemodonac Castilla Y Leon, Valladolid, Castilla Y Leon, Spain
来源
PLOS ONE | 2022年 / 17卷 / 02期
关键词
COVID-19;
D O I
10.1371/journal.pone.0264124
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background The vast majority of COVID-19 cases both symptomatic and asymptomatic develop immunity after COVID-19 contagion. Whether lasting differences exist between infection and vaccination boosted immunity is yet to be known. The aim of this study was to determine how long total anti-SARS-CoV2 antibodies due to past infection persist in peripheral blood and whether sex, age or haematological features can influence their lasting. Material and methods A series of 2421 donations either of SARS-CoV-2 convalescent plasma or whole blood from 1107 repeat donors from January 2020 to March 2021 was analysed. An automated chemiluminescence immunoassay for total antibodies recognizing the nucleocapsid protein of SARS-CoV-2 in human serum and plasma was performed. Sex, age, blood group, blood cell counts and percentages and immunoglobulin concentrations were extracted from electronic recordings. Blood donation is allowed after a minimum of one-month post symptom's relapse. Donors were 69.7% males and their average age was 46. The 250 donors who had later donations after a positive one underwent further analysis. Both qualitative (positivity) and quantitative (rise or decline of optical density regarding consecutive donations) outcomes were evaluated. Results and discussion In 97.6% of donors with follow-up, anti-SARS-CoV-2 protein N total antibodies remained positive at the end of a follow-up period of 12.4 weeks median time (1-46, SD = 9.65) after the first positive determination. The blood group was not related to antibody waning. Lower lymphocyte counts and higher neutrophils would help predict future waning or decay of antibodies. Most recovered donors maintain their total anti-SARS-CoV-2 N protein antibodies for at least 16 weeks (at least one month must have been awaited from infection resolution to blood donation). The 10 individuals that could be followed up longer than 40 weeks (approximately 44 weeks after symptom's relapse) were all still positive.
引用
收藏
页数:12
相关论文
共 28 条
  • [1] Estimation of US SARS-CoV-2 Infections, Symptomatic Infections, Hospitalizations, and Deaths Using Seroprevalence Surveys
    Angulo, Frederick J.
    Finelli, Lyn
    Swerdlow, David L.
    [J]. JAMA NETWORK OPEN, 2021, 4 (01)
  • [2] In Nasal Mucosal Secretions, Distinct IFN and IgA Responses Are Found in Severe and Mild SARS-CoV-2 Infection
    Batista dos Santos, Juliana de Melo
    Soares, Camila Pereira
    Monteiro, Fernanda Rodrigues
    Mello, Ralyria
    do Amaral, Jonatas Bussador
    Aguiar, Andressa Simoes
    Soledade, Mariana Pereira
    Sucupira, Carolina
    De Paulis, Milena
    Andrade, Juliana Bannwart
    Almeida, Flavia Jaqueline
    Palazzi Safadi, Marco Aurelio
    Mau, Luciana Becker
    Brasil, Jamile Menezes
    Ramalho, Theresa
    Loures, Flavio, V
    Vieira, Rodolfo Paula
    Durigon, Edison Luiz
    Leal de Oliveira, Danielle Bruna
    Lacerda Bachi, Andre Luis
    [J]. FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [3] Serosurveillance for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Incidence Using Global Blood Donor Populations
    Busch, Michael P.
    Stone, Mars
    [J]. CLINICAL INFECTIOUS DISEASES, 2021, 72 (02) : 254 - 256
  • [4] COVID-19 Makes B Cells Forget, but T Cells Remember
    Canete, Pablo F.
    Vinuesa, Carola G.
    [J]. CELL, 2020, 183 (01) : 13 - 15
  • [5] Distinct phenotypes of platelet, monocyte, and neutrophil activation occur during the acute and convalescent phase of COVID-19
    Chao, Yashuan
    Rebetz, Johan
    Blackberg, Anna
    Hovold, Gisela
    Sunnerhagen, Torgny
    Rasmussen, Magnus
    Semple, John W.
    Shannon, Oonagh
    [J]. PLATELETS, 2021, 32 (08) : 1092 - 1102
  • [6] Changes in SARS-CoV-2 Spike versus Nucleoprotein Antibody Responses Impact the Estimates of Infections in Population-Based Seroprevalence Studies
    Fenwick, Craig
    Croxatto, Antony
    Coste, Alix T.
    Pojer, Florence
    Andre, Cyril
    Pellaton, Celine
    Farina, Alex
    Campos, Jeremy
    Hacker, David
    Lau, Kelvin
    Bosch, Berend-Jan
    Nussle, Semira Gonseth
    Bochud, Murielle
    D'Acremont, Valerie
    Trono, Didier
    Greub, Gilbert
    Pantaleo, Giuseppe
    [J]. JOURNAL OF VIROLOGY, 2021, 95 (03)
  • [7] Intrafamilial Exposure to SARS-CoV-2 Associated with Cellular Immune Response without Seroconversion, France
    Gallais, Floriane
    Velay, Aurelie
    Nazon, Charlotte
    Wendling, Marie-Josee
    Partisani, Marialuisa
    Sibilia, Jean
    Candon, Sophie
    Fafi-Kremer, Samira
    [J]. EMERGING INFECTIOUS DISEASES, 2021, 27 (01) : 113 - 121
  • [8] Primary, Recall, and Decay Kinetics of SARS-CoV-2 Vaccine Antibody Responses
    Ibarrondo, F. Javier
    Hofmann, Christian
    Fulcher, Jennifer A.
    Goodman-Meza, David
    Mu, William
    Hausner, Mary Ann
    Ali, Ayub
    Balamurugan, Arumugam
    Taus, Ellie
    Elliott, Julie
    Krogstad, Paul
    Tobin, Nicole H.
    Ferbas, Kathie G.
    Kitchen, Scott G.
    Aldrovandi, Grace M.
    Rimoin, Anne W.
    Yang, Otto O.
    [J]. ACS NANO, 2021, 15 (07) : 11180 - 11191
  • [9] Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients
    Isho, Baweleta
    Abe, Kento T.
    Zuo, Michelle
    Jamal, Alainna J.
    Rathod, Bhavisha
    Wang, Jenny H.
    Li, Zhijie
    Chao, Gary
    Rojas, Olga L.
    Bang, Yeo Myong
    Pu, Annie
    Christie-Holmes, Natasha
    Gervais, Christian
    Ceccarelli, Derek
    Samavarchi-Tehrani, Payman
    Guvenc, Furkan
    Budylowski, Patrick
    Li, Angel
    Paterson, Aimee
    Yue, Feng Yun
    Marin, Lina M.
    Caldwell, Lauren
    Wrana, Jeffrey L.
    Colwill, Karen
    Sicheri, Frank
    Mubareka, Samira
    Gray-Owen, Scott D.
    Drews, Steven J.
    Siqueira, Walter L.
    Barrios-Rodiles, Miriam
    Ostrowski, Mario
    Rini, James M.
    Durocher, Yves
    McGeer, Allison J.
    Gommerman, Jennifer L.
    Gingras, Anne-Claude
    [J]. SCIENCE IMMUNOLOGY, 2020, 5 (52)
  • [10] COVID-19: age, Interleukin-6, C-reactive protein, and lymphocytes as key clues from a multicentre retrospective study
    Jurado, Aurora
    Martin, Maria C.
    Abad-Molina, Cristina
    Orduna, Antonio
    Martinez, Alba
    Ocana, Esther
    Yarce, Oscar
    Navas, Ana M.
    Trujillo, Antonio
    Fernandez, Luis
    Vergara, Esther
    Rodriguez, Beatriz
    Quirant, Bibiana
    Martinez-Caceres, Eva
    Hernandez, Manuel
    Perurena-Prieto, Janire
    Gil, Juana
    Cantenys, Sergi
    Gonzalez-Martinez, Gema
    Martinez-Saavedra, Maria T.
    Rojo, Ricardo
    Marco, Francisco M.
    Mora, Sergio
    Ontanon, Jesus
    Lopez-Hoyos, Marcos
    Ocejo-Vinyals, Gonzalo
    Melero, Josefa
    Aguilar, Marta
    Almeida, Delia
    Medina, Silvia
    Vegas, Maria C.
    Jimenez, Yesenia
    Prada, Alvaro
    Monzon, David
    Boix, Francisco
    Cunill, Vanesa
    Molina, Juan
    [J]. IMMUNITY & AGEING, 2020, 17 (01)